Database studies in post-marketing surveillance in Japan: Perspective from the industry
-
- Aoki Kotonari
- Real World Data Science Dept., Chugai Pharmaceutical Co., LTD., Japan
抄録
<p>It can be said that April 1, 2018 is an anniversary on which drug epidemiology was fully introduced in Japanese pharmacovigilance activities. It can also be said that the concept of comparing treatment options and the secondary use of medical data are "welcomed" from the administrative side, Independence Day. Well, 3 months after that, how did Japanese pharmacovigilance begin to change? I would like to outline this from the standpoint of a pharmaceutical company employee and look forward to the future - with optimism hope.</p>
収録刊行物
-
- 日本薬理学会年会要旨集
-
日本薬理学会年会要旨集 WCP2018 (0), SY38-4-, 2018
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390567172571235712
-
- NII論文ID
- 130007902499
-
- ISSN
- 24354953
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可